Skip to content

Author

M. Jamal-Hanjani

We have 3 of 33 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinoma

Extensive validation will be needed to convert PATH-ORACLE from a prognostic biomarker to a predictive biomarker that could be used to prioritize stage IB patients for adjuvant targeted therapy, chemotherapy, or immune checkpoint inhibitor therapy with or without liquid biopsy-based monitoring.

O. Kilim, O. Pipek, Z. Sztupinszki et al. · 0 citations
Open access Sep 2026

Tumor-Secreted ADAMTSL4 Activates Latent TGFβ1 to Drive Cancer Cachexia

Tumor-secreted ADAMTSL4 activates latent TGFβ1 at muscle cell surfaces, promoting muscle atrophy and fibrosis while also driving adipose tissue wasting, and represents a selective therapeutic target for cancer cachexia.

J. Machado, Vignesh Karthikaisamy, Hermine Mohr et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.